Target
Kallikrein-1
Ligand
BDBM50541586
Substrate
n/a
Meas. Tech.
ChEMBL_1984905 (CHEMBL4618311)
Ki
>30000±n/a nM
Citation
 Yang, WWang, YLai, AClark, CGCorte, JRFang, TGilligan, PJJeon, YPabbisetty, KBRampulla, RAMathur, AKaspady, MNeithnadka, PRArumugam, ARaju, SRossi, KAMyers, JESheriff, SLou, ZZheng, JJChacko, SABozarth, JMWu, YCrain, EJWong, PCSeiffert, DALuettgen, JMLam, PYSWexler, RREwing, WR Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species. J Med Chem 63:7226-7242 (2020) [PubMed]  Article
Target
Name:
Kallikrein-1
Synonyms:
KLK1 | KLK1_HUMAN | Kallikrein 1 | Kallikrein-1 | Kidney/pancreas/salivary gland kallikrein | Tissue kallikrein
Type:
Enzyme
Mol. Mass.:
28874.69
Organism:
Homo sapiens (Human)
Description:
P06870
Residue:
262
Sequence:
MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS
  
Inhibitor
Name:
BDBM50541586
Synonyms:
CHEMBL4638245
Type:
Small organic molecule
Emp. Form.:
C31H29ClF2N4O4
Mol. Mass.:
595.036
SMILES:
COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1 |r,c:22|
Structure:
Search PDB for entries with ligand similarity: